INBIOGEN Valuation

Is A101140 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A101140 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A101140's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A101140's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A101140?

Key metric: As A101140 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A101140. This is calculated by dividing A101140's market cap by their current revenue.
What is A101140's PS Ratio?
PS Ratio	6.2x
Sales	₩10.58b
Market Cap	₩65.30b

A101140 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.4x
Enterprise Value/EBITDA	-15x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does A101140's PS Ratio compare to its peers?

The above table shows the PS ratio for A101140 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.4x
A006060 HWASEUNG IndustriesLtd	0.1x	n/a	₩201.6b
A900110 East Asia Holdings Investment	0.4x	n/a	₩27.6b
A241590 Hwaseung Enterprise	0.4x	12.7%	₩529.6b
A102280 SBW	0.7x	n/a	₩70.6b
A101140 INBIOGEN	6.2x	n/a	₩65.3b

Price-To-Sales vs Peers: A101140 is expensive based on its Price-To-Sales Ratio (6.2x) compared to the peer average (0.5x).

Price to Sales Ratio vs Industry

How does A101140's PS Ratio compare vs other companies in the KR Luxury Industry?

4 Companies	Price / Sales	Estimated Growth	Market Cap
A016450 Hansae Yes24 Holdings	0.06x	n/a	US$124.38m
A079980 Huvis	0.09x	n/a	US$56.24m
A007980 TP	0.07x	n/a	US$46.46m
A323230 MFM KOREA	0.1x	n/a	US$5.17m

No more companies available in this PS range

4 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: A101140 is expensive based on its Price-To-Sales Ratio (6.2x) compared to the KR Luxury industry average (0.5x).

Price to Sales Ratio vs Fair Ratio

What is A101140's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A101140 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	6.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A101140's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.